NIT
NKTR icon

NumerixS Investment Technologies’s Nektar Therapeutics NKTR Stock Holding History

NumerixS Investment Technologies’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,415
Closed -$458K – 1186
2019
Q4 		$458K Buy
+1,415
New +$410K 0.09% 251
2018
Q4 		– Sell
-999
Closed -$913K – 1270
2018
Q3 		$913K Buy
999
+32
+3% +$27.3K 0.17% 172
2018
Q2 		$699K Buy
+967
New +$1.12M 0.16% 177
2017
Q1 		– Sell
-1,407
Closed -$259K – 1299
2016
Q4 		$259K Sell
1,407
-1,463
-51% -$297K 0.03% 592
2016
Q3 		$740K Buy
+2,870
New +$739K 0.1% 264
2015
Q3 		– Sell
-851
Closed -$160K – 733
2015
Q2 		$160K Buy
+851
New +$146K 0.02% 600
2015
Q1 		– Sell
-1,536
Closed -$357K – 651
2014
Q4 		$357K Buy
+1,536
New +$328K 0.12% 252

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

NumerixS Investment Technologies's NKTR Position: Q1 2020 in Review

NumerixS Investment Technologies sold out of Nektar Therapeutics (NKTR) in Q1 2020, closing a stake of 1,415 shares — an estimated $458K sold.

NumerixS Investment Technologies first reported a position in NKTR in Q4 2014 and held it in 7 quarters. The position peaked at $913K in Q3 2018. 244 funds tracked by Wall St. Rank hold NKTR as of Q1 2020.

  • NumerixS Investment Technologies reported no remaining Nektar Therapeutics position as of Q1 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 1,415 Nektar Therapeutics shares in Q1 2020, an estimated $458K.
  • NumerixS Investment Technologies first reported a position in Nektar Therapeutics in Q4 2014 and held it in 7 quarters.
  • NumerixS Investment Technologies's Nektar Therapeutics position peaked at $913K in Q3 2018.
  • 244 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2020.

Based on NumerixS Investment Technologies's 13F filing for Q1 2020, filed 15 May 2020.